The Department of Veterans Affairs (VA) awarded a $294,606,092.21 single-award indefinite delivery contract to Boston Scientific Corp, doing business as Boston Scientific, to provide surgical implants and related services. The contract has an ultimate completion date of December 31, 2025. Under this IDC, the VA has issued multiple delivery orders to Boston Scientific for a variety of medical devices including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, drug-coated balloons, catheters, stents, and surgical implants. The total value of these delivery orders exceeds $3.8 million to date. Boston Scientific, a leading medical device manufacturer, also holds separate IDIQs with the VA worth $3.5 million for TheraSphere Y-90 radioactive microspheres used in interventional radiology and $85,000 for maintenance and support of the Polaris iLab Imaging System. These contracts demonstrate Boston Scientific's role as a key supplier of innovative, minimally invasive medical technologies and services to support federal healthcare initiatives, particularly for the veteran population.
In addition to the prime contract awards, Boston Scientific has been involved in federally funded research and development efforts as a subrecipient. This includes collaboration with Baylor College of Medicine on a National Institutes of Health project to develop an implantable pulse generator for modulating the autonomic nervous system, which could potentially treat conditions like rheumatoid arthritis and inflammatory bowel disease. Boston Scientific's responsibilities include preparing documentation, developing firmware/software, and conducting testing for the experimental WaveWriter Alpha device.
Generated 1/8/25, 9:04 AM